Here are what the editors at HealthDay consider to be the most important developments in Dermatology for August 2017. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Minimal Evidence for Electronic Communication Guidelines
THURSDAY, Aug. 31, 2017 (HealthDay News) — Minimal evidence is available for guidelines for electronic communication between patients and providers, according to research published online Aug. 28 in the Journal of the American Medical Informatics Association.
W-Plasty Closure in Posterior Occipital Hairline Acceptable
THURSDAY, Aug. 31, 2017 (HealthDay News) — For closures in the posterior occipital hairline, cosmetic outcomes are similar for primary W-plasty and traditional straight-line (SL) trichophytic closure techniques, according to a study published online Aug. 24 in JAMA Facial Plastic Surgery.
Proactive Approach Encouraged for Online Patient Reviews
WEDNESDAY, Aug. 30, 2017 (HealthDay News) — Most patients are using online reviews as a first step to finding a new doctor, with 65 percent forming an opinion from reading one to six reviews, according to a report published in Medical Economics.
Most Melanomas Don’t Start As Existing Moles
WEDNESDAY, Aug. 30, 2017 (HealthDay News) — The majority of melanomas arise from new lesions rather than existing moles, according to a review published online Aug. 29 in the Journal of the American Academy of Dermatology.
Platelet-Rich Plasma Effective for Chronic Venous Leg Ulcers
TUESDAY, Aug. 29, 2017 (HealthDay News) — For patients with chronic venous leg ulcers, autologous platelet-rich plasma (PRP) is safe and effective, with highly significant improvement in ulcer size compared to conventional treatment, according to a study published online Aug. 19 in the Journal of Cosmetic Dermatology.
CO2 Laser + Platelet-Rich Plasma Promising Treatment for Vitiligo
MONDAY, Aug. 28, 2017 (HealthDay News) — Combination of fractional carbon dioxide (CO2) laser with platelet-rich plasma (PRP) injection is a promising treatment for vitiligo, according to a study published online Aug. 20 in the Journal of Cosmetic Dermatology.
Links Between Emotional Well-Being, Aesthetic Dermatology
FRIDAY, Aug. 25, 2017 (HealthDay News) — There is a positive relationship between attitude toward aesthetic dermatology treatments and emotional well-being, according to a study published online Aug. 18 in the Journal of Cosmetic Dermatology.
Noninvasive Test for NASH, Fibrosis in Patients With Psoriasis
FRIDAY, Aug. 25, 2017 (HealthDay News) — For patients with psoriasis receiving long-term methotrexate sodium therapy, a noninvasive test for nonalcoholic steatohepatitis (NASH) and hepatic fibrosis (NASH FibroSure) can be used to monitor development of methotrexate-induced hepatotoxic effects, with a significant correlation for cumulative methotrexate dose with higher score in women, but not men, according to research published online Aug. 23 in JAMA Dermatology.
ART Era Has Changed Secondary Cancers After Kaposi Sarcoma
FRIDAY, Aug. 25, 2017 (HealthDay News) — There has been a significant decline in the risk of secondary cancers after Kaposi sarcoma (KS) in the era of highly-active antiretroviral therapy (HAART), according to a study published online Aug. 24 in JAMA Oncology.
Platelet-Rich Plasma + Hyaluronic Acid Improves Skin Rejuvenation
THURSDAY, Aug. 24, 2017 (HealthDay News) — Autologous platelet-rich plasma (PRP) combined with hyaluronic acid (HA) improves skin firmness and elasticity, according to a research letter published in the September issue of the Journal of the American Academy of Dermatology.
Myricetin Potentially Protective Against Photodamage of Skin
THURSDAY, Aug. 24, 2017 (HealthDay News) — Myricetin protects cells from photodamage via the IκB/NFκB signaling pathway, according to a study published online Aug. 17 in the Journal of Cosmetic Dermatology.
Good Cosmetic Outcomes for Super Pulse CO2 Laser Therapy
WEDNESDAY, Aug. 23, 2017 (HealthDay News) — Super pulse carbon dioxide (CO2) laser is associated with good cosmetic outcomes for benign eyelid lesions, according to a study published online Aug. 17 in the Journal of Cosmetic Dermatology.
Nurse-, System-Related Factors Analyzed in Wrong-Patient Events
WEDNESDAY, Aug. 23, 2017 (HealthDay News) — Greater focus is needed on correct identification processes in order to prevent wrong-patient medication administration incidents, and system supports for nurses are critical, according to a study published online Aug. 17 in the Journal of Clinical Nursing.
Leukomelanoderma After Hydroquinone Use Described
WEDNESDAY, Aug. 23, 2017 (HealthDay News) — In a case report published online Aug. 16 in the Journal of Dermatology, leukomelanoderma is described in patients using hydroquinone at a concentration of 10 percent.
Hours Worked Impacted by Kids for Female, Not Male Doctors
MONDAY, Aug. 21, 2017 (HealthDay News) — For women, but not men, in dual-physician couples, weekly hours worked are lower for those with versus those without children, according to a research letter published online Aug. 21 in JAMA Internal Medicine.
Arsenic Levels Higher in Patients With Nonmelanoma Skin Cancers
MONDAY, Aug. 21, 2017 (HealthDay News) — Certain arsenic species levels are higher among patients with nonmelanoma skin cancer (NMSC), according to a study published online Aug. 16 in the Journal of Dermatology.
Early, Single Non-Ablative Fractional Laser Tx Aids Scarring
MONDAY, Aug. 21, 2017 (HealthDay News) — Early, single non-ablative fractional laser (NAFL) exposure can offer improvement in clinical scar appearance, according to a study published online Aug. 16 in Lasers in Surgery and Medicine.
Candida Antigen Safe, Effective for Treating Common Warts
FRIDAY, Aug. 18, 2017 (HealthDay News) — Candida antigen is a promising, effective, and safe immunotherapeutic treatment for common warts, according to a study published online Aug. 8 in the International Journal of Dermatology.
Limited Economic Evidence for Vitiligo Treatments
THURSDAY, Aug. 17, 2017 (HealthDay News) — The cost burden associated with vitiligo is high, although no evidence exists for the value of vitiligo treatments, according to a research letter published online Aug. 10 in the British Journal of Dermatology.
Frequency, Degree of Pubic Hair Grooming Linked to Injury Risk
WEDNESDAY, Aug. 16, 2017 (HealthDay News) — The frequency and degree of pubic hair grooming is associated with the risk of grooming-related injury and high-frequency injury, according to a study published online Aug. 16 in JAMA Dermatology.
Variable Square Pulse Erbium Promising for Stretch Marks
WEDNESDAY, Aug. 16, 2017 (HealthDay News) — Resurfacing with a variable square pulse Erbium: YAG (VSP Er:YAG) laser is a promising treatment option for stretch marks, according to a small study published online Aug. 9 in the Journal of Cosmetic Dermatology.
Studies Used for FDA Approval of Device Changes Often Low Quality
TUESDAY, Aug. 15, 2017 (HealthDay News) — Many studies used to support U.S. Food and Drug Administration approval of high-risk medical device modifications are not controlled; and efficacy of drugs granted accelerated approval is often confirmed three years after approval, according to two studies published in the Aug. 15 issue of the Journal of the American Medical Association.
Abstract/Full Text – Zheng (subscription or payment may be required)
Abstract/Full Text – Naci (subscription or payment may be required)
Editorial (subscription or payment may be required)
Specialist Access No Better With Adoption of Access Standards
TUESDAY, Aug. 15, 2017 (HealthDay News) — Adoption of specialty access standards does not improve access to specialists, according to a study published online Aug. 14 in JAMA Internal Medicine.
Majority of Derm Clinic Patients Express Interest in Anti-Aging Tx
FRIDAY, Aug. 11, 2017 (HealthDay News) — Patients are largely unfamiliar with most anti-aging treatment options, but are interested in pursuing future treatment, according to a study published online Aug. 3 in the Journal of Cosmetic Dermatology.
Intradermal LMW-HA Injection Reduces Enlarged Facial Pores
THURSDAY, Aug. 10, 2017 (HealthDay News) — Intradermal injection of low molecular weight hyaluronic acid (LMW-HA) can significantly improve skin texture, reduce pore size, and enhance skin radiance, according to a study published online Aug. 8 in the Journal of Cosmetic Dermatology.
Probiotics in Infancy Do Not Reduce Incidence of Eczema
TUESDAY, Aug. 8, 2017 (HealthDay News) — Probiotic administration during the first six months of life does not reduce the incidence of eczema at 2 years of age or asthma at 5 years of age, according to a study published online Aug. 7 in Pediatrics.
Guidance Provided for Preventing Practice Billing Errors
MONDAY, Aug. 7, 2017 (HealthDay News) — Strategies can help to prevent medical practice billing errors, according to a report published in Medical Economics.
Review: Antibiotics Effectively Prevent Recurrent Cellulitis
MONDAY, Aug. 7, 2017 (HealthDay News) — Antibiotic prophylaxis can prevent recurrence of cellulitis, according to a review published online June 20 in the Cochrane Library.
Revenue Exceeds Expenditures for Many ABMS Member Boards
WEDNESDAY, Aug. 2, 2017 (HealthDay News) — Overall revenue exceeds expenditures for many American Board of Medical Specialties (ABMS) member boards, according to a study published in the Aug. 1 issue of the Journal of the American Medical Association.
ABP 501, Adalimumab Biosimilar, Safe and Effective, for Psoriasis
WEDNESDAY, Aug. 2, 2017 (HealthDay News) — The biosimilar ABP 501 has similar clinical efficacy and safety to adalimumab for the treatment of moderate-to-severe plaque psoriasis, according to a study published online July 28 in the British Journal of Dermatology.
Periodontal Disease History Linked to Increased Cancer Risk
TUESDAY, Aug. 1, 2017 (HealthDay News) — Among older women, periodontal disease history is associated with increased total cancer risk, and with increased risk of several specific types of cancer, according to a study published in the Aug. 1 issue of Cancer, Epidemiology, Biomarkers & Prevention.
Copyright © 2017 ScoutNews, LLC. All rights reserved.
